Skip to content
Stop using now Drug recall · FDA · Published September 13, 2021

Viatris Candesartan Cilexetil Tablets 16mg Recall: Impurities Risk Serious Harm

Viatris recalls 16mg Candesart: Impurities may cause serious harm. Affected lots from October 2021. Stop using and contact for replacement.

🇺🇸 FDA recall #D-0798-2021DrugViatris ›
Take action

Contact the company

Recalling firmViatris781 Chestnut Ridge Rd · Morgantown, WV 26505-2730
✎ GovInfoNow plain-language explainer

Viatris is recalling 16mg Candesartan Cilexetil tablets due to impurities that could cause serious harm. This affects specific batches made in October 2021. Consumers should stop using these products immediately. Read more at govinfonow.com/recall/35856-viatris-candesartan-cilexetil-tablets-16mg-recall-impurities-risk-serious-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/35856-viatris-candesartan-cilexetil-tablets-16mg-recall-impurities-risk-serious-harm · Updated August 18, 2026 · FDA enforcement record: FDA #D-0798-2021

Cite this page

“Viatris Candesartan Cilexetil Tablets 16mg Recall: Impurities Risk Serious Harm.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35856-viatris-candesartan-cilexetil-tablets-16mg-recall-impurities-risk-serious-harm. Based on FDA recall #D-0798-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0798-2021%22&limit=1).

The FDA announced on September 13, 2021, that Viatris is recalling Candesartan Cilexetil Tablets, USP 16 mg, manufactured for Mylan Pharmaceuticals Inc., due to failed impurity specifications. The recall involves 21,094 units distributed nationwide.

How to tell if you have it

  • Brand: Viatris
  • Product: Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles
  • Manufacturer: Mylan Pharmaceuticals Inc., Morgantown, WV
  • NDC: 0378-3231-93
  • Lot #: 3107334
  • Expiration date: October 2021

The hazard

The product failed impurity and degradation specifications, specifically being out of specification for Related Compound. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Viatris has one other recall on record since August 23, 2021: the Lyrica CR 330mg Tablets Recall for failed dissolution specifications. Other recent recalls of similar products include the Xanax XR 3mg Tablets Recall (March 17, 2026) and the Cinacalcet Tablets Recall (November 14, 2025).

How to tell if you have this one

Check for the 16mg strength, 30-count bottles, and lot number 3107334 with an expiration date of October 2021. The product was manufactured by Viatris for Mylan Pharmaceuticals.

  • Brand
    Viatris
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled tablets as they may contain harmful impurities.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Sep 13, 202112. FDA classified it Class III: Sep 14, 202123. Published in FDA’s Enforcement Report: Sep 22, 202134. FDA terminated the recall: Apr 28, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0798-2021 (September 13, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0798-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA